Statin Use May Protect Against Esophageal Cancer

Bon Secours Harbour View Endoscopy Center, HALO Ablation, Barrett's Esophagus treatment Hampton Roads, cancer careAccording to new information presented at the American College of Gastroenterology Annual Scientific Meeting, patients taking statins experienced reduced risk for developing esophageal cancer.

In a systematic review and meta-analysis, researchers found that patients who used statins were less likely to develop esophageal cancer.  Patients with a longer duration of statin use and those who used statins in addition to nonsteroidal anti-inflammatory drugs and/or aspirin had an ever greater drop in risk.

Experts are excited about the findings of these studies, which support a “protective association” between statin use and esophageal cancer, especially in patients with Barrett’s Esophagus. Given the high mortality rates after a diagnosis of esophageal cancer, these results support chemoprevention trials evaluating statins in populations at high risk of developing cancer.

Read more articles about Barrett’s Esophagus!


Speak Your Mind